|
BE637271A
(https=)
|
1963-04-04 |
1900-01-01 |
|
|
|
NL128365C
(https=)
|
1963-11-05 |
|
|
|
|
US3449427A
(en)
|
1965-06-03 |
1969-06-10 |
Smithkline Corp |
Aminocyclopropane derivatives of 5h-dibenzo(a,d)cycloheptenes
|
|
US3697506A
(en)
|
1970-08-07 |
1972-10-10 |
Pfizer |
Crystalline alkali metal salts of {60 -carboxybenzylpenicillin and process therefor
|
|
US3686335A
(en)
|
1970-12-21 |
1972-08-22 |
Smith Kline French Lab |
5-vinyl-5h-di benzo(a,d)cycloheptenes
|
|
US4432987A
(en)
*
|
1982-04-23 |
1984-02-21 |
Pfizer Inc. |
Crystalline benzenesulfonate salts of sultamicillin
|
|
US4547505A
(en)
|
1983-03-25 |
1985-10-15 |
Degussa Aktiengesellschaft |
N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production
|
|
CS244821B2
(en)
|
1983-06-16 |
1986-08-14 |
Boehringer Ingelheim Ltd |
Production method of new substituted phenylalkyl(piperazinyl or homopiperazinyle)-prpylureas or thioureas
|
|
DE3418167A1
(de)
|
1984-05-16 |
1985-11-21 |
Bayer Ag, 5090 Leverkusen |
Verwendung von amiden zur verbesserung der kulturpflanzen-vertraeglichkeit von herbizid wirksamen heteroaryloxyacetamiden
|
|
DE3600288A1
(de)
|
1986-01-08 |
1987-07-16 |
Bayer Ag |
Verwendung von amiden zur verbesserung der kulturpflanzen-vertraeglichkeit von herbizid wirksamen sulfonylharnstoff-derivaten
|
|
DE3618004A1
(de)
|
1986-05-28 |
1987-12-03 |
Bayer Ag |
Verwendung von amiden zur verbesserung der kulturpflanzen-vertraeglichkeit von herbizid wirksamen sulfonyliso(thio)-harnstoff-derivaten
|
|
EP0507863A4
(en)
|
1989-12-28 |
1993-07-07 |
Virginia Commonwealth University |
Sigma receptor ligands and the use thereof
|
|
EP0435320B1
(en)
|
1989-12-29 |
1994-10-05 |
Banyu Pharmaceutical Co., Ltd. |
2(2-Cyclopropylpyrrolidin-4-ylthio)-carbapenem derivatives
|
|
AU2505392A
(en)
|
1991-08-22 |
1993-03-16 |
Monsanto Company |
Safening herbicidal pyrazolylsulfonylureas
|
|
DE4131139A1
(de)
|
1991-09-19 |
1993-03-25 |
Bayer Ag |
Verfahren zur herstellung von 1-fluor-cyclopropan-1-carbonsaeure
|
|
US5721359A
(en)
|
1993-03-12 |
1998-02-24 |
Pharmacia & Upjohn Company |
Crystalline ceftiofur free acid
|
|
AU4368996A
(en)
|
1994-11-23 |
1996-06-17 |
Neurogen Corporation |
Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
|
|
US5604253A
(en)
|
1995-05-22 |
1997-02-18 |
Merck Frosst Canada, Inc. |
N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors
|
|
US5859246A
(en)
|
1997-01-30 |
1999-01-12 |
Neurogen Corporation |
1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands
|
|
US6124299A
(en)
|
1997-02-24 |
2000-09-26 |
Zymogenetics, Inc. |
Calcitonin mimetics
|
|
US6160134A
(en)
|
1997-12-24 |
2000-12-12 |
Bristol-Myers Squibb Co. |
Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
|
|
TR200002182T2
(tr)
|
1998-01-27 |
2000-12-21 |
Aventis Pharmaceuticals Products Inc. |
İkame edilmiş aksozaherosayklil faktör xa inhibitörleri
|
|
US6268367B1
(en)
|
1998-02-23 |
2001-07-31 |
Zymogenetics, Inc. |
Piperazine derivatives for treating bone deficit conditions
|
|
US6383520B1
(en)
|
1998-06-26 |
2002-05-07 |
Chugai Seiyaku Kabushiki Kaisha |
Fine powder of L-α-aminoadipic acid derivative, oral solid preparations containing the same, and method for treatment of bulk powders
|
|
US6284761B1
(en)
|
1999-01-08 |
2001-09-04 |
Neurogen Corporation |
1-phenyl-4-(1-[2-aryl]cyclopropyl)methylpiperazines: dopamine receptor ligands
|
|
JP2002534421A
(ja)
|
1999-01-08 |
2002-10-15 |
ニューロゲン コーポレイション |
１−フェニル−４−（１−［２−アリール］シクロプロピル）メチルピペラジン：ドーパミン受容体リガンド
|
|
GB9913083D0
(en)
*
|
1999-06-04 |
1999-08-04 |
Novartis Ag |
Organic compounds
|
|
AU5426500A
(en)
|
1999-06-16 |
2001-01-02 |
Takeda Chemical Industries Ltd. |
Benzazepine derivatives, process for the preparation of the same and uses thereof
|
|
WO2001022963A1
(en)
|
1999-09-27 |
2001-04-05 |
Merck & Co., Inc. |
Method of preventing osteoporosis
|
|
WO2001051919A2
(en)
|
2000-01-07 |
2001-07-19 |
Transform Pharmaceuticals, Inc. |
High-throughput formation, identification, and analysis of diverse solid-forms
|
|
US6521619B2
(en)
|
2000-06-29 |
2003-02-18 |
Icos Corporation |
Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents
|
|
AU2001268724B2
(en)
|
2000-06-29 |
2005-06-16 |
Abbott Laboratories |
Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
|
|
JP2004525071A
(ja)
|
2000-07-20 |
2004-08-19 |
ニューロジェン コーポレイション |
カプサイシン受容体リガンド
|
|
WO2002051781A1
(fr)
|
2000-12-25 |
2002-07-04 |
Ajinomoto Co., Inc. |
Procede permettant de preparer un compose d'halohydrine optiquement actif
|
|
PL364625A1
(en)
*
|
2001-02-23 |
2004-12-13 |
Merck & Co, Inc. |
N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
|
|
EP1421071B1
(en)
|
2001-07-02 |
2009-11-18 |
High Point Pharmaceuticals, LLC |
Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators
|
|
US7262185B2
(en)
|
2001-08-08 |
2007-08-28 |
Takeda Chemical Industries Ltd. |
Benzazepine derivative, process for producing the same, and use
|
|
US7145002B2
(en)
|
2001-09-26 |
2006-12-05 |
Merck & Co. Inc. |
Crystalline forms of carbapenem antibiotics and methods of preparation
|
|
AU2002363236A1
(en)
*
|
2001-10-30 |
2003-05-12 |
Millennium Pharmaceuticals, Inc. |
Compounds, pharmaceutical compositions and methods of use therefor
|
|
US6861432B2
(en)
*
|
2001-11-23 |
2005-03-01 |
Schering Aktiengesellschaft |
Piperazine derivatives that destabilize androgen receptors
|
|
JP2005526800A
(ja)
|
2002-03-22 |
2005-09-08 |
エルジー・ライフ・サイエンシーズ・リミテッド |
（２Ｓ）−Ｎ−５−［アミノ（イミノ）メチル］−２−チエニルメチル−１−（２Ｒ）−２−［（カルボキシルメチル）アミノ］−３，３−ジフェニルプロパノイル−２−ピロリジンカルボキサミド・ｎＨ２Ｏの新しい結晶形
|
|
AU2003236686A1
(en)
|
2002-06-07 |
2003-12-22 |
Altana Pharma Ag |
4,5-dihydro-imidazo(4,5,1-j) quinolin-6-ones as parp inhibitors
|
|
US20040209858A1
(en)
|
2002-10-22 |
2004-10-21 |
Bennani Youssef L. |
Cycloalkylamides and their therapeutic applications
|
|
US20040077618A1
(en)
|
2002-10-22 |
2004-04-22 |
Bennani Youssef L. |
Cycloalkylamides and their therapeutic applications
|
|
JPWO2004046110A1
(ja)
|
2002-11-15 |
2006-03-16 |
アステラス製薬株式会社 |
メラニン凝集ホルモン受容体拮抗剤
|
|
US7569579B2
(en)
|
2002-12-13 |
2009-08-04 |
Smithkline Beecham Corporation |
Cyclopropyl compounds as ccr5 antagonists
|
|
PL1615909T3
(pl)
|
2003-04-23 |
2009-01-30 |
Glaxo Group Ltd |
Pochodne piperazyny i ich zastosowanie w leczeniu chorób neurologicznych i psychicznych
|
|
DK1618092T3
(da)
|
2003-05-01 |
2011-01-31 |
Bristol Myers Squibb Co |
Aryl-substituerede pyrazol-amidforbindelser, der er anvendelige som kinasehæmmere
|
|
AR045595A1
(es)
|
2003-09-04 |
2005-11-02 |
Vertex Pharma |
Composiciones utiles como inhibidores de proteinas quinasas
|
|
JP2007516982A
(ja)
|
2003-12-15 |
2007-06-28 |
日本たばこ産業株式会社 |
シクロプロパン化合物及びその医薬用途
|
|
CA2573198A1
(en)
|
2004-07-06 |
2006-02-09 |
Xenon Pharmaceuticals Inc. |
Nicotinamide derivatives and their use as therapeutic agents
|
|
AR050865A1
(es)
|
2004-09-09 |
2006-11-29 |
Sanofi Aventis |
Derivados de 2- morfolino-4-pirimidona
|
|
PT1805164E
(pt)
|
2004-09-29 |
2011-04-11 |
Sanofi Aventis |
Derivados de 6-(piridinil)-4-pirimidona como inibidores de proteína-cinase tau 1
|
|
EP1802307B1
(en)
|
2004-10-15 |
2008-02-27 |
Glaxo Group Limited |
Pyrrolidine derivatives as histamine receptors ligands
|
|
KR20070106690A
(ko)
|
2004-12-27 |
2007-11-05 |
아스트라제네카 아베 |
피라졸론 화합물 및 대사성 글루타메이트 수용체길항제로서 그들의 용도
|
|
CA2595882A1
(en)
*
|
2005-01-26 |
2006-08-03 |
Pharmacia & Upjohn Company Llc |
Thieno [2,3-d] pyrimidine compounds as inhibitors of adp-mediated platelets aggregation
|
|
JP2008530162A
(ja)
|
2005-02-15 |
2008-08-07 |
グラクソ グループ リミテッド |
グルタミン酸受容体を増強する化合物および医薬におけるそれらの使用
|
|
ES2528674T3
(es)
|
2005-02-17 |
2015-02-11 |
Astellas Pharma Inc. |
Piperidina y carboxilatos de piperacina como inhibidores de FAAH
|
|
EP1874780A1
(en)
|
2005-03-25 |
2008-01-09 |
Pharmacia & Upjohn Company LLC |
4-piperazinylthieno[2,3-d]pyrimidine compounds as platelet aggregation inhibitors
|
|
EP1869051A1
(en)
|
2005-03-28 |
2007-12-26 |
Pharmacia & Upjohn Company LLC |
4-piperazinylthieno ý2,3-d¨pyrimidine compounds as platelet aggregation inhibitors
|
|
CA2603041A1
(en)
|
2005-03-28 |
2006-10-05 |
Pharmacia & Upjohn Company Llc |
4-piperazinylthieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors
|
|
JP2008534573A
(ja)
|
2005-03-28 |
2008-08-28 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
血小板凝集阻害剤としての４−ピペラジノチエノ［２，３−ｄ］ピリミジン化合物
|
|
WO2007011623A1
(en)
|
2005-07-15 |
2007-01-25 |
Schering Corporation |
Quinazoline derivatives useful in cancer treatment
|
|
TW200740779A
(en)
*
|
2005-07-22 |
2007-11-01 |
Mitsubishi Pharma Corp |
Intermediate compound for synthesizing pharmaceutical agent and production method thereof
|
|
US7851474B2
(en)
|
2005-08-02 |
2010-12-14 |
Neurogen Corporation |
Dipiperazinyl ketones and related analogues
|
|
KR101336106B1
(ko)
|
2005-09-16 |
2013-12-05 |
얀센 파마슈티카 엔.브이. |
히스타민 ｈ3 수용체의 조절제로서 사이클로프로필 아민
|
|
US8158673B2
(en)
|
2005-10-27 |
2012-04-17 |
Pfizer Inc. |
Histamine-3 receptor antagonists
|
|
MX367916B
(es)
|
2005-10-31 |
2019-09-11 |
Janssen Pharmaceutica N V Star |
Procedimientos para la preparacion de derivados de ciclopropilamida.
|
|
NZ593074A
(en)
|
2005-12-21 |
2012-04-27 |
Vertex Pharma |
sulfonamide-pyrrolidone derivatives as Modulators of Ion Channels
|
|
US8119668B2
(en)
|
2005-12-23 |
2012-02-21 |
Nelson Erik B |
Treatment methods employing histamine H3 receptor antagonists, including betahistine
|
|
AU2007204426A1
(en)
|
2006-01-13 |
2007-07-19 |
F. Hoffmann-La Roche Ag |
Cyclohexyl piperazinyl methanone derivatives and their use as histamine H3 receptor modulators
|
|
CN101384581B
(zh)
*
|
2006-02-17 |
2013-09-18 |
弗·哈夫曼-拉罗切有限公司 |
作为5ht2/d3调节剂的苯甲酰基-哌啶衍生物
|
|
JP2009528240A
(ja)
|
2006-03-01 |
2009-08-06 |
セメンテク・ピーティーワイ・リミテッド |
メーソンリー部材用マトリックス及びその製造方法
|
|
JP2009132621A
(ja)
|
2006-03-13 |
2009-06-18 |
Ajinomoto Co Inc |
シクロプロピルアミド化合物の製造方法
|
|
JP2009530390A
(ja)
|
2006-03-23 |
2009-08-27 |
アムゲン インコーポレイティッド |
１−フェニルスルホニル−ジアザ複素環アミド化合物およびヒドロキシステロイドデヒドロゲナーゼ調節因子としてのその使用
|
|
WO2007138928A1
(ja)
|
2006-05-26 |
2007-12-06 |
Kaneka Corporation |
光学活性３－アミノ－２－ヒドロキシプロピオン酸シクロプロピルアミド誘導体およびその塩の製造方法
|
|
CN103382174A
(zh)
|
2006-06-23 |
2013-11-06 |
雅培制药有限公司 |
作为组胺h3受体调节物的环丙胺衍生物
|
|
US9108948B2
(en)
|
2006-06-23 |
2015-08-18 |
Abbvie Inc. |
Cyclopropyl amine derivatives
|
|
US20100016293A1
(en)
|
2006-07-03 |
2010-01-21 |
Rogier Adriaan Smits |
Quinazolines and Related Heterocyclic Compounds, and Their Therapeutic Use
|
|
GB0615620D0
(en)
*
|
2006-08-05 |
2006-09-13 |
Astrazeneca Ab |
A process for the preparation of optically active intermediates
|
|
EP2056828A4
(en)
*
|
2006-08-21 |
2010-06-23 |
Merck Sharp & Dohme |
SULFONYLATED PIPERAZINES AS CANNABINOID-1 RECEPTOR MODULATORS
|
|
TW200828371A
(en)
*
|
2006-09-21 |
2008-07-01 |
Matsushita Electric Industrial Co Ltd |
Chip-type filter
|
|
DE102006056526A1
(de)
*
|
2006-11-30 |
2008-06-05 |
Archimica Gmbh |
Verfahren zur stereoselektiven Synthese von chiralen Epoxiden durch ADH-Reduktion von alpha-Abgangsgruppen-substituierten Ketonen und Cyclisierung
|
|
US7737149B2
(en)
|
2006-12-21 |
2010-06-15 |
Astrazeneca Ab |
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
|
|
WO2008147864A2
(en)
|
2007-05-22 |
2008-12-04 |
Xenon Pharmaceuticals Inc. |
Methods of using piperazine compounds in treating sodium channel-mediated diseases or conditions
|
|
WO2008150364A1
(en)
|
2007-05-23 |
2008-12-11 |
Merck & Co., Inc. |
Cyclopropyl pyrrolidine orexin receptor antagonists
|
|
JP2010529157A
(ja)
|
2007-06-11 |
2010-08-26 |
エフ．ホフマン−ラ ロシュ アーゲー |
シクロヘキシル誘導体
|
|
SA08290520B1
(ar)
*
|
2007-08-22 |
2012-02-22 |
استرازينيكا ايه بي |
مشتقات سيكلو بروبيل أميد وتركيبات صيدلية تحتوي عليها لعلاج حالة مرضية سببها مستقبلات هيستامين h3
|
|
MX2010003155A
(es)
*
|
2007-10-04 |
2010-04-01 |
Hoffmann La Roche |
Derivados de ciclopropil aril amida y uso de los mismos.
|
|
PE20091313A1
(es)
|
2008-01-15 |
2009-09-03 |
Lilly Co Eli |
(r)-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida cristalina
|
|
DE102008049371A1
(de)
|
2008-03-06 |
2009-09-10 |
Mühlbauer Ag |
Einrichtung mit einem RFID-Transponder in einem elektrisch leitfähigen Gegenstand und Herstellungsverfahren hierfür
|
|
NZ588634A
(en)
*
|
2008-03-20 |
2012-03-30 |
Forest Lab Holdings Ltd |
Novel piperazine derivatives as inhibitors of stearoyl-coa desaturase
|
|
BRPI0913057A2
(pt)
*
|
2008-05-08 |
2015-10-13 |
Evotec Ag |
azetidinas e ciclobutanos como antagonistas de receptor de histamina h3
|
|
US8586607B2
(en)
|
2008-07-28 |
2013-11-19 |
Syddansk Universitet |
Compounds for the treatment of metabolic diseases
|
|
CN101462980B
(zh)
|
2009-01-05 |
2013-01-09 |
扬州天辰精细化工有限公司 |
2，6—二氟苯甲酰胺的工业化生产方法
|
|
TW201039825A
(en)
*
|
2009-02-20 |
2010-11-16 |
Astrazeneca Ab |
Cyclopropyl amide derivatives 983
|
|
JP5746718B2
(ja)
|
2010-02-18 |
2015-07-08 |
アストラゼネカ・アクチエボラーグＡｓｔｒａｚｅｎｅｃａ Ａｋｔｉｅｂｏｌａｇ |
シクロプロピルアミド誘導体からなる固体形態
|
|
RU2012139082A
(ru)
|
2010-02-18 |
2014-03-27 |
Астразенека Аб |
Способы получения производных циклопропиламида и связанных с ними промежуточных соединений
|